|
RAPT Rapt Therapeutics Inc 1673772 |
| Balance Sheet |
|
Current Assets
|
102,598,000 |
|
Assets
|
108,465,000 |
|
Current Liabilities
|
10,362,000 |
|
Liabilities
|
12,959,000 |
|
Equity
|
95,506,000 |
|
Shares Out
|
34,903,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-72,860,000 |
|
Investing Cash Flow
|
53,545,000 |
| Market Analysis |
Market Cap
|
66,840,143 |
|
Price
|
1.20 |
|
BVPS
|
2.74 |
|
PB
|
0.45 |
|
EPS
|
-3.12 |
|
PS
|
0.85 |
|
FCF
|
-19,315,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RAPT documents filed with the SEC.
RAPT Filings
Clear
